When you think of the gifts science has given society, what comes to mind?
So often, scientific advancement is associated solely with technology, when in reality the most prominent example of its effect in modern culture is in healthcare. As science continues to march forward, so do its implications on global health.
While there are plenty of pharmaceutical companies charging toward cures and treatments for common ailments, AstraZeneca works to set itself apart in a number of ways. It is unique in a world when medicine has become so extremely corporate, and resists the corporate mentality.
While many major pharmaceutical players are concerned with Europe and the United States, AstraZeneca takes a different approach. By focusing on markets that are still emerging, particularly those in Asia, AstraZeneca is able to eat up more market share in these areas, though they do maintain a global presence.
By throwing their energy into a few main research areas (Oncology, Cardiovascular, and Respiratory), they are better able to seek out specific solutions aimed at improving the lives of patients all over the world. Headquartered in England and Sweden, this company follows in whatever direction the science points.
A Lucrative Merger
AstraZeneca, as it’s known today, was formed in 1999 when a Swedish and British company merged to form the conglomerate. The earliest of the two companies to form was Astra, a 1913 venture by hundreds of doctors to create reliable medication.
In the more than a hundred years since, both of the predecessors to AstraZeneca did significant research and brought many solutions to the market. Now, their products are available in more than 100 countries, and the company continues to grow, though they strive to maintain an entrepreneurial spirit.
Money in Medicine
Given the massive profits that can be earned from bringing new medications to market, it’s no surprise that pharmaceutical companies aren’t exactly difficult to come by. As such, AstraZeneca has no shortage of competition.
Companies like AbbVie and Johnson & Johnson are just two examples of other companies with similar goals. However, the important distinction is that AstraZeneca focuses mainly on markets that are not as widely targeted.
A Winding Road
Though AstraZeneca is, indeed, one of the largest pharmaceutical companies in the world, they’ve had their fair share of bad publicity. From patent fights to bribing doctors, most of this bad press has mirrored the same sort of issues other pharmaceutical companies have faced.
Rather than succumbing to these tough times, AstraZeneca forged on, and appears to be re-emerging stronger than ever. This speaks to the overall strength of the company: a few tough years don’t make or break a genuinely healthy business.
The Next Chapter
As of 2019, AstraZeneca is poised for continued success. The brand ranks at 237 on the Forbes Global 2000 list. With a market cap of more than $99 billion, it’s hard to believe that AstraZeneca was ever struggling. What’s more, the company also ranks number 57 on the list of America’s Best Employers.
With its eye always on innovation, there’s no telling what AstraZeneca might come up with next in its specialized fields of research. A renewed focus within their strategy and success to prove its working can only serve to reinvigorate this pharmaceutical giant.
People will never stop getting sick. On a regular basis, new illnesses and ailments arise and are discovered. That is why companies like AstraZeneca try to match the discovery of illness with the discovery of cure. Companies like AstraZeneca are here to solve the mysteries of the body and bring health within reach, both in the short-term and the long-term future.